Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
291 Leser
Artikel bewerten:
(1)

Bioprocess Container Market size worth $ 2.59 Billion, Globally, by 2028 at 12.6% CAGR: Verified Market Research

Finanznachrichten News

Increasing demand for biologics and the rise in production of vaccines using single-use disposable technology, sustainability and affordability of single-use bioprocess technology and lower risk of cross-contamination are likely to propel the market.

JERSEY CITY, N.J., April 14, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Bioprocess Container Market" By Type (2D Bioprocess Containers, 3D Bioprocess Containers), By Application (Upstream Processes, Downstream Processes), By End-User (Life Science R&D Companies, Biopharmaceutical Companies), and By Geography. According to Verified Market Research, the Global Bioprocess Container Market size was valued at USD 1.00 Billion in 2020 and is projected to reach USD 2.59 Billion by 2028, growing at a CAGR of 12.6% from 2021 to 2028.

Verified Market Research Logo

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=27673

Browse in-depth TOC on "Bioprocess Container Market"

202 - Pages

126 - Tables

37 - Figures

Global Bioprocess Container Market Overview

Increasing demand for biologics and the rise in production of vaccines using single-use disposable technology are factors expected to foster the growth of the Global Bioprocess Container Market. Additionally, sustainability and affordability of single-use bioprocess technology and lower risk of cross-contamination propel the market growth. The increased demand for better, cheaper, and faster biologics manufacturing has fueled the growth of single-use technologies. The active development of individualized biologics and personalized medications, such as patient-specific cellular and gene therapies and therapeutic vaccinations, need a high level of sterility, which is why single-use equipment and consumables are used.

The COVID-19 pandemic resulted in the unprecedented demand for vaccines. Owing to the pandemic, more large-scale and laboratory-scale single-use bioreactors, as well as related consumables such as bioprocess containers, media bags, filtration assemblies, and other consumables, are being used. However, high issues associated with extractable and leachable bioprocess containers and the high cost of instruments might act as a restraining factor to the growth of the market. Single-use systems (SUS) provide a number of benefits over traditional bio-manufacturing methods, including less process validation requirements and more manufacturing flexibility, which leads to increased operating efficiency and lower manufacturing costs.

Key Developments

  • In April 2021: Sartorius Stedim Biotech (France) opened a new Customer Interaction Center (CIC) in Beijing, China, to increase its presence in the country and meet the rising demand for biopharmaceuticals.
  • In March 2021: Merck KGaA (Germany) invested USD 30 million (EUR 25 million) at its Life Science Center in Molsheim, France, to add a single-use assembly production unit. With this development, the business is speeding up its plans to expand single-use technology throughout Europe, which is used to make COVID-19 vaccines and other life-saving therapies.

Key Players

The major players in the market are Thermo Fisher Scientific, Sartorius AG, Rim Bio, Merck KGaA, Meissner, Lonza, GE Healthcare, Fluidscontrol, Fenner, Danaher.

Verified Market Research has segmented the Global Bioprocess Container Market On the basis of Type, Application, End-User, and Geography.

  • Bioprocess Container Market, By Type
    • 2D Bioprocess Containers
    • 3D Bioprocess Containers
    • Other Containers & Accessories
  • Bioprocess Container Market, By Application
    • Upstream Processes
    • Downstream Processes
    • Process Development
  • Bioprocess Container Market, By End-User
    • Life Science R&D Companies
    • Biopharmaceutical Companies
  • Bioprocess Container Market by Geography
    • North America
      • U.S
      • Canada
      • Mexico
      • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Bioprocess Technology Market By Type (Cell Culture, Cell Expansion, Flow Cytometry), By Application (Biopharmaceuticals, Specialty products, Industrial chemicals), By End-User (Hospitals, Research Labs and Centers, Medical Institutions), By Geography, Forecast, 2021-2028

Single-Use Bioprocessing Market By Product (Apparatus & Plants, Simple & Peripheral Elements, Work Equipment), By Workflow (Upstream, Fermentation, Downstream), By End Use (Biopharmaceutical Manufacturer and Academic & Clinical Research Institutes), By Geography, Forecast, 2021-2028

Bioprocess Analyzers Market By Product (Instruments and Consumables), By Application (Antibiotics, Recombinant Proteins, Biosimilars), By Geography, Forecast, 2021-2028

Single-use Bioprocessing Sensors Market By Type (Electrochemical, Optical), By Application (Biotechnology Industry, Pharmaceutical Industry), By Geography, Forecast, 2021-2028

Top 5 Bio-Based Materials Companies focusing on a carbon neutral future

Visualize Bioprocess Container Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.